With the company looking to expand its operation at international level and attract support from all potential partners, Halo Labs has announced that Mr Met will be tasked with among other things to expand Bophelo’s operations to deliver the highest quality product at scale.
He will also be expected to establish the company’s international distribution base as well as sell to a broad base of potential countries in the European Union and the United Kingdom.
Halo is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils, and concentrates. The company has sold approximately six million grams of oils and concentrates since inception.
Bophelo Bioscience and Wellness on the other hand is a subsidiary of the Canadian Company Halo Labs and intends to operate one of the largest cannabis cultivation sites in the world as well as distribute high-quality cannabis products.
Based in Mafeteng, Bophelo is the holder of one of a limited number of licenses issued in Lesotho for the production of medical cannabis products and holds a massive land package of over 200 hectares.
“I am thrilled to have the opportunity to develop what is expected to be one of the world’s largest grow operation. Bophelo’s nine-year license allows it to cultivate, manufacture, import and export cannabis products. The opportunity to oversee a cultivation site that is up to eighty-two times larger at 494 acres (200 hectares) is the opportunity of a lifetime,” Mr Met said in a statement.
The company has expressed confidence in the CEO, citing that his background is well suited to execute Halo’s international expansion.
Mr Met conducted the first medical grow on a quarter acre at the company’s East Evans Creek site in 2016. The following year, according to the company, he oversaw the expansion of East Evans Creek to six acres and further led the development of all manufacturing and sales activities from the ground.
